Spruce Biosciences, Inc. (SPRB)
USD 0.08
(-0.63%)
USD 0.08
(-0.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -33.27 Million | -41.68 Million | -35.87 Million | -27.51 Million | -12.61 Million | -8.57 Million |
| Net Income | -47.91 Million | -46.18 Million | -42.29 Million | -29.53 Million | -13.08 Million | -9.85 Million |
| Depreciation & Amortization | 70 Thousand | 74 Thousand | 68 Thousand | 36 Thousand | 12 Thousand | 1000.00 |
| Deferred income taxes | -1.9 Million | - | 121 Thousand | - | -446 Thousand | - |
| Stock-based compensation | 4.62 Million | 3.63 Million | 3.95 Million | 755 Thousand | 196 Thousand | 101 Thousand |
| Change in working capital | 10.35 Million | 1.13 Million | 1.95 Million | 1.16 Million | 263 Thousand | 1.18 Million |
| Other non-cash items | 1.5 Million | -340 Thousand | 313 Thousand | 66 Thousand | 446 Thousand | -1.59 Million |
| Investing Cash Flow | 55.77 Million | 23.69 Million | -79.16 Million | -74 Thousand | -4000.00 | - |
| Investments in PPE | -7000.00 | -8000.00 | -93 Thousand | -74 Thousand | -4000.00 | - |
| Acquisitions | -55.78 Million | -23.7 Million | - | - | - | - |
| Investment purchases | -11.88 Million | -36.8 Million | -79.07 Million | - | - | - |
| Sales/Maturities of investments | 67.66 Million | 60.5 Million | 121 Thousand | - | - | - |
| Other Investing Activities | 55.78 Million | 23.7 Million | -121 Thousand | - | - | - |
| Financing Cash Flow | 49.14 Million | -241 Thousand | 643 Thousand | 181.03 Million | 12.43 Million | - |
| Debt repayment | -1.62 Million | - | -230 Thousand | - | -4.5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -311 Thousand | -40 Thousand | 134 Thousand | - | - | - |
| Common Stock Issuance | 51.07 Million | -201 Thousand | 423 Thousand | 96.25 Million | 12.43 Million | - |
| Other Financing Activities | 51.07 Million | -201 Thousand | 413 Thousand | 84.78 Million | 12.43 Million | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.9 Million | -1.39 Million | 1.14 Million | 3.73 Million | -226 Thousand | 1.69 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 8.45 Million | 2.52 Million | 806 Thousand | -2.57 Million | 489 Thousand | -511 Thousand |
| Cash at beginning of period | 24.7 Million | 42.96 Million | 157.36 Million | 3.92 Million | 4.11 Million | 12.68 Million |
| Cash at end of period | 96.33 Million | 24.73 Million | 42.96 Million | 157.36 Million | 3.92 Million | 4.11 Million |
| Capital Expenditure | -7000.00 | -8000.00 | -93 Thousand | -74 Thousand | -4000.00 | - |
| Effect of forex changes on cash | -6000.00 | - | - | - | - | - |
| Net cash flow / Change in cash | 71.63 Million | -18.23 Million | -114.4 Million | 153.44 Million | -188 Thousand | -8.57 Million |
| Free Cash Flow | -33.28 Million | -41.69 Million | -35.97 Million | -27.59 Million | -12.62 Million | -8.57 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.18 Million | -11.62 Million | -9.95 Million | -47.91 Million | -12.35 Million | -12.82 Million |
| Depreciation & Amortization | 12 Thousand | 15 Thousand | 16 Thousand | 70 Thousand | 17 Thousand | 18 Thousand |
| Deferred income taxes | - | - | -1.07 Million | -1.9 Million | -138 Thousand | -249 Thousand |
| Stock-based compensation | 1.68 Million | 1.56 Million | 1.22 Million | 4.62 Million | 1.12 Million | 1.21 Million |
| Change in working capital | -3.68 Million | -4.97 Million | -2.48 Million | 10.35 Million | -973 Thousand | 13.77 Million |
| Other non-cash items | 2.98 Million | 3.09 Million | 1.06 Million | 1.5 Million | 57 Thousand | 56 Thousand |
| Investing Cash Flow | - | - | 9.3 Million | 55.77 Million | 13.99 Million | 22 Million |
| Investments in PPE | - | - | - | -7000.00 | -7000.00 | - |
| Acquisitions | - | - | - | -55.78 Million | - | - |
| Investment purchases | - | - | - | -11.88 Million | - | - |
| Sales/Maturities of investments | - | - | 9.3 Million | 67.66 Million | 14 Million | 22 Million |
| Other Investing Activities | - | - | 9.3 Million | 55.78 Million | 14 Million | 22 Million |
| Financing Cash Flow | -365 Thousand | -227 Thousand | -552 Thousand | 49.14 Million | -405 Thousand | -432 Thousand |
| Debt repayment | -406 Thousand | -405 Thousand | -406 Thousand | -1.62 Million | -405 Thousand | -406 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -11 Thousand | -2000.00 | -217 Thousand | -311 Thousand | - | -71 Thousand |
| Common Stock Issuance | 52 Thousand | 180 Thousand | 71 Thousand | 51.07 Million | - | 45 Thousand |
| Other Financing Activities | -11 Thousand | -2000.00 | 71 Thousand | 51.07 Million | - | 45 Thousand |
| Accounts receivables | - | - | - | - | - | 15 Million |
| Accounts payables | -1.2 Million | -1.44 Million | 180 Thousand | 1.9 Million | 2.2 Million | -2.5 Million |
| Inventory | - | - | 15 Million | - | - | -15 Million |
| Other working capital | -2.47 Million | -3.52 Million | -2.66 Million | 8.45 Million | -3.18 Million | 16.27 Million |
| Cash at beginning of period | 81.15 Million | 96.33 Million | 98.8 Million | 24.7 Million | 97.51 Million | 73.95 Million |
| Cash at end of period | 69.68 Million | 81.15 Million | 96.33 Million | 96.33 Million | 98.83 Million | 97.51 Million |
| Capital Expenditure | - | - | - | -7000.00 | -7000.00 | - |
| Effect of forex changes on cash | - | - | -1000.00 | -6000.00 | -536 Thousand | -22.65 Million |
| Net cash flow / Change in cash | -11.47 Million | -15.18 Million | -2.46 Million | 71.63 Million | 1.31 Million | 23.56 Million |
| Free Cash Flow | -11.1 Million | -14.95 Million | -11.2 Million | -33.28 Million | -12.27 Million | 1.99 Million |
FSRL
FNGR
DPZUF
GOLECHA
CHGX
HR